Articles From: Lilly Declares Fourth-Quarter 2013 Dividend to Lilly USA, LLC Launches New Rotation Program for Medical Students


INDIANAPOLIS , Oct.
Sign-up for Lilly Declares Fourth-Quarter 2013 Dividend investment picks
2014/2/12
More than half a million dollars donated to help children with diabetes attend camp since 2008 INDIANAPOLIS and ALEXANDRIA, Va.
Sign-up for Lilly Diabetes Donates 91 Scholarships to Support the American Diabetes Association's Diabetes Summer Camp Program investment picks
Eli Lilly & Co.
Sign-up for Lilly Diabetes Drug Ruled Comparable to Market Leader investment picks
2013/11/19
New sponsorship of "Red Riders®"--cyclists with diabetes--added in 5 cities INDIANAPOLIS , Nov.
Sign-up for Lilly Diabetes Extends National Sponsorship of the American Diabetes Association's Signature Tour de Cure® Cycling Event for a Second Year investment picks
2013/10/11
INDIANAPOLIS and ALEXANDRIA, Va.
Sign-up for Lilly Diabetes Sponsors the American Diabetes Association and NASCAR Driver Ryan Reed to Increase Diabetes Awareness and Education investment picks
Renewed commitment over two years helps support education for students with type 1 diabetes INDIANAPOLIS and ROLLING MEADOWS, Ill.
Sign-up for Lilly Diabetes to contribute $200,000 to the Diabetes Scholars Foundation investment picks
New resources housed on T1EverydayMagic.com combine the expertise of Lilly Diabetes with the magic of Disney INDIANAPOLIS , Dec.
Sign-up for Lilly Diabetes/Disney Custom Books for Type 1 Diabetes Families Now Available Online investment picks
Company Remains Committed to Alzheimer's Disease Research and Development to Bring Innovative New Products to Patients Who Need Them Most INDIANAPOLIS , Sept.
Sign-up for Lilly Disappointed in Medicare Decision to Deny Appropriate Patient Access to Beta-Amyloid Imaging Agents, Including Amyvid™ (Florbetapir F 18 Injection), Despite Support From Experts, Patients and the Alzheimer's Disease Community investment picks
2013/9/30
Company Remains Committed to Alzheimer's Disease Research and Development to Bring Innovative New Products to Patients Who Need Them Most INDIANAPOLIS , Sept.
Sign-up for Lilly Disappointed in Medicare Decision to Deny Appropriate Patient Access to Beta-Amyloid Imaging Agents, Including Amyvid™ (Florbetapir F 18 Injection), Despite Support From Experts, Patients and the Alzheimer's Disease Community investment picks
By Michael Calia Eli Lilly & Co.
Sign-up for Lilly Lung Cancer Treatment Meets Primary Endpoint in Phase III Trial investment picks
16th annual scholarship program for individuals living with severe and persistent mental illness expands to include those living with major depressive disorder INDIANAPOLIS , Oct.
Sign-up for Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year investment picks
Company communicates progress on numerous indicators of economic, environmental, and social performance INDIANAPOLIS , Dec.
Sign-up for Lilly Releases Report on Corporate Responsibility Efforts investment picks
2014/1/30
INDIANAPOLIS , Jan.
Sign-up for Lilly Reports Fourth-Quarter and Full-Year 2013 Results investment picks
INDIANAPOLIS , Oct.
Sign-up for Lilly Reports Third-Quarter 2013 Results investment picks
2014/4/8
INDIANAPOLIS , April 8, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) issued the following statement today in response to the verdict in the case of Terrence Allen , et al.
Sign-up for Lilly Responds to Verdict in Case of Terrence Allen, et al. v. Takeda investment picks
2014/1/31
Eli Lilly & Co., facing a lawsuit by Sanofi SA, said it doesn't believe one of its proposed new insulin products infringes upon patents covering Sanofi's Lantus insulin.
Sign-up for Lilly Says New Product Doesn't Infringe Patents investment picks
2013/11/19
INDIANAPOLIS , Nov.
Sign-up for Lilly Statement on Contribution to Indiana Biosciences Research Institute investment picks
2013/9/30
INDIANAPOLIS , Sept.
Sign-up for Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013 investment picks
2014/3/5
INDIANAPOLIS , March 5, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the Barclays Global Healthcare Conference on Wednesday, March 12, 2014 .
Sign-up for Lilly to Participate in Barclays Healthcare Conference investment picks
2014/2/21
INDIANAPOLIS , Feb.
Sign-up for Lilly to Participate in Cowen Healthcare Conference investment picks
2014/2/5
INDIANAPOLIS , Feb.
Sign-up for Lilly to Participate in Leerink Swann Global Healthcare Conference investment picks
INDIANAPOLIS , Dec.
Sign-up for Lilly to Present at J.P. Morgan Healthcare Conference investment picks
Company to showcase late-stage pipeline, including efficacy, safety and patient-reported health outcomes data for investigational GLP-1 receptor agonist INDIANAPOLIS , Sept.
Sign-up for Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting investment picks
Lilly Foundation matches donations from employees, retirees to support children, families in communities across U.S. INDIANAPOLIS , Nov.
Sign-up for Lilly to Present Record-Breaking $12.6 Million Gift to United Way investment picks
2014/4/6
INDIANAPOLIS , April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies – including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 – that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif.
Sign-up for Lilly To Release Early-Stage Pipeline Data Targeting Key Cancer Pathways At AACR 2014 investment picks
2013/10/3
Eli Lilly & Co.
Sign-up for Lilly Unveils $5 Billion Share Repurchase Program investment picks
2014/2/12
Tulane University School of Medicine participates in pilot program INDIANAPOLIS , Feb.
Sign-up for Lilly USA, LLC Launches New Rotation Program for Medical Students investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Lilly Declares Fourth-Quarter 2013 Dividend to Lilly USA, LLC Launches New Rotation Program for Medical Students
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity